Provided by Tiger Trade Technology Pte. Ltd.

iBio

2.35
-0.0600-2.49%
Volume:616.63K
Turnover:1.47M
Market Cap:76.47M
PE:-1.68
High:2.45
Open:2.42
Low:2.34
Close:2.41
52wk High:6.89
52wk Low:0.5562
Shares:32.54M
Float Shares:21.44M
Volume Ratio:0.99
T/O Rate:2.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4000
EPS(LYR):-1.7504
ROE:-54.50%
ROA:-28.82%
PB:1.36
PE(LYR):-1.34

Loading ...

iBio files to sell 11.06M shares of common stock for holders

TIPRANKS
·
Jan 31

Ibio Inc: Files Prospectus for Resale of up to 11.1 Mln Shares Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jan 31

iBio Announces Private Placement to Fund Pipeline Expansion

TIPRANKS
·
Jan 13

iBio prices 11.06M shares at $2.35 in private placement

TIPRANKS
·
Jan 09

Ibio Announces $26 Million Private Placement

THOMSON REUTERS
·
Jan 09

Press Release: iBio Announces $26 Million Private Placement

Dow Jones
·
Jan 09

Ecor1 Capital Llc Reports 9.9% Passive Stake in Ibio Inc as of Dec 10- SEC Filing

THOMSON REUTERS
·
Dec 18, 2025

iBio Inc. Held Annual Shareholder Meeting

Reuters
·
Nov 21, 2025

iBio Inc. Releases Updated Corporate Presentation

Reuters
·
Nov 18, 2025

iBio Inc. Files Amendment to Quarterly 10-Q Report

Reuters
·
Nov 17, 2025

iBio Q1 EPS $(0.11) Misses $(0.10) Estimate, Sales $100.000K Beat $25.000K Estimate

Benzinga
·
Nov 13, 2025

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Nov 13, 2025

iBio Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)

TIPRANKS
·
Nov 06, 2025

iBio Regains Nasdaq Compliance with Bid Price Rule

TIPRANKS
·
Nov 05, 2025

iBio management to meet with Oppenheimer

TIPRANKS
·
Nov 03, 2025

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

GlobeNewswire
·
Oct 30, 2025

iBio price target raised to $6 from $5 at Oppenheimer

TIPRANKS
·
Oct 30, 2025

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire
·
Oct 23, 2025

Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target

MT Newswires Live
·
Oct 21, 2025